ArticleCancers2026
Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND/
objectivesKi67 is a well-established histologic proliferation marker across many cancers; however, its clinical application in pancreatic ductal adenocarcinoma (PDAC) has remained limited. Multiple studies have demonstrated that Ki67 is prognostic in PDAC, with higher Ki67 expression associated with worsened outcomes. In this study, we aimed to characterize the underlying biology of Ki67-enriched tumors.
methodsClinical and transcriptional data from PDAC patients were obtained from The Cancer Genome Atlas (TCGA) and three Gene Expression Omnibus (GEO) datasets. Mutational analysis from the TCGA cohort was also performed. Patients within each study were stratified into low- and high-expression groups based on the median transcript levels. Each dataset was analyzed independently, and differences between groups were subsequently compared across studies.
resultsConsistent with their enhanced proliferative capacity,
conclusions
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.